Ontozry 150mg (Cenobamate Tablet) 150mg

ONTOZRY 150MG (cenobamate) is an anticonvulsant tablet prescribed for seizure management in adults. This 150mg strength formulation supports stable dosing for epilepsy treatment. Ideal for long-term epilepsy care with ambient storage. A trusted option for seizure control under medical supervision.

Strength

150mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

ANGELINI

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ONTOZRY 150MG is primarily used to reduce seizures in adults with epilepsy. It is prescribed when other treatments have not adequately controlled focal-onset seizures. This medication helps stabilize electrical activity in the brain to prevent seizure episodes. It is not intended for use in children or as a first-line treatment.

Side Effects

ONTOZRY 150MG may help reduce the frequency and severity of seizures over time. Some users report improved daily functioning and reduced seizure-related anxiety. Effects vary by individual, and consistent use is important for best results. It may take several weeks to notice the full benefits.

Precautions & Warnings

ONTOZRY 150MG should be stored at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not crush or split tablets unless advised by a healthcare provider. Report any unusual side effects, such as dizziness or mood changes, to a medical professional promptly.

Avoid Interactions

ONTOZRY 150MG may interact with other central nervous system depressants, including alcohol and certain sedatives. Caution is advised when combining with medications that affect liver enzymes, such as CYP inhibitors. Always inform your doctor about all medications, supplements, and herbal products you are taking.

Frequently Asked Questions

ONTOZRY 150MG is used to help reduce seizures in adults with epilepsy, particularly focal-onset seizures.

Store ONTOZRY 150MG at room temperature, away from moisture and direct sunlight.

Consult your doctor before combining ONTOZRY 150MG with other medications, as interactions may occur.

Effects may take several weeks to become noticeable; consistent use is important for best results.

ONTOZRY 150MG is not approved for use in children; it is prescribed for adults only.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.